New Confidence: Optimizing Benchmark Dose Modeling to Improve Risk Assessment

نویسندگان

چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

New Confidence: Optimizing Benchmark Dose Modeling
to Improve Risk Assessment

Benchmark dose (BMD) modeling has been touted as a more accu­ rate method for conducting chemical risk assessments. In this issue of EHP, a team of researchers applied BMD modeling to hundreds of chemicals whose health effects are already known in an effort to optimize the approach. To calculate the highest safe oral dose of a noncarcinogenic chem­ ical, regulators must first estimate the point...

متن کامل

Review of Noncancer Risk Assessment: Application of Benchmark Dose Methods

The overall goal of this project is to evaluate risk assessment methods traditionally used for noncancer health risks and to compare them with new approaches. Initially this report gives a brief economic rationale for the impact of prevention of noncancer health effects. This is shown using figures for years of potential life lost which reveal that noncancer health effects, such as birth defect...

متن کامل

Leveraging Epidemiology to Improve Risk Assessment

The field of environmental public health is at an important crossroad. Our current biomonitoring efforts document widespread exposure to a host of chemicals for which toxicity information is lacking. At the same time, advances in the fields of genomics, proteomics, metabolomics, genetics and epigenetics are yielding volumes of data at a rapid pace. Our ability to detect chemicals in biological ...

متن کامل

Quantitative risk analysis for N-methyl pyrrolidone using physiologically based pharmacokinetic and benchmark dose modeling.

Establishing an occupational exposure limit (OEL) for N-methyl pyrrolidone (NMP) is important due to its widespread use as a solvent. Based on studies in rodents, the most sensitive toxic end point is a decrease in fetal/pup body weights observed after oral, dermal, and inhalation exposures of dams to NMP. Evidence indicates that the parent compound is the causative agent. To reduce the uncerta...

متن کامل

Use of NOAEL , benchmark dose , and other models for human risk assessment of hormonally active substances * , †

The benchmark dose (BMD) is the dose of a substance that is expected to result in a prespecified level of effect, the benchmark response level or BMR. It is a general approach to characterizing dose response, applicable to any toxicant and endpoint. A BMD is conceptually superior to a “no observed adverse effect level” (NOAEL) for this purpose because of being less determined by experimental de...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Environmental Health Perspectives

سال: 2014

ISSN: 0091-6765,1552-9924

DOI: 10.1289/ehp.122-a138